Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 43.33
-1.67 (-3.70%)
Jun 16, 2026, 8:00 AM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 91.3 million as of June 15, 2026. Its market cap has decreased by -67.60% in one year.
Market Cap
91.30M
Enterprise Value
102.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
43.33
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 91.30M, an increase of 70.77%. That is a compound annual growth rate of 5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 91.30M | -55.67% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 332.51M |
| PureTech Health | 319.36M |
| Scancell Holdings | 202.37M |
| Bioventix | 84.90M |
| 4basebio | 81.58M |
| Ondine Biomedical | 67.54M |
| hVIVO | 58.05M |
| Hemogenyx Pharmaceuticals | 56.13M |